<SEC-DOCUMENT>0001193125-24-260003.txt : 20241118
<SEC-HEADER>0001193125-24-260003.hdr.sgml : 20241118
<ACCEPTANCE-DATETIME>20241115182930
ACCESSION NUMBER:		0001193125-24-260003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20241114
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241118
DATE AS OF CHANGE:		20241115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COHERENT CORP.
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39375
		FILM NUMBER:		241469376

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	II-VI INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d695449d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cohr="http://www.coherent.com/20241114" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-506">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-11-14_to_2024-11-14">0000820318</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cohr-20241114.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-11-14_to_2024-11-14"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000820318</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-11-14</xbrli:startDate> <xbrli:endDate>2024-11-14</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-517">8-K</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt:datemonthdayyearen" id="ixv-518">November 14, 2024</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-519">Coherent Corp.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:stateprovnameen" id="ixv-520">Pennsylvania</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-521">001-39375</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-522">25-1214948</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-523">375 Saxonburg Boulevard</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-524">Saxonburg</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:stateprovnameen" id="ixv-525">Pennsylvania</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-526">16056</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-527">(724)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-528">352-4455</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:boolballotbox" id="ixv-529">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:boolballotbox" id="ixv-530">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:boolballotbox" id="ixv-531">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:boolballotbox" id="ixv-532">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-533">Common Stock, no par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-534">COHR</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:exchnameen" id="ixv-535">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-11-14_to_2024-11-14" format="ixt-sec:boolballotbox" id="ixv-536">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Coherent Corp. (the &#8220;Company&#8221;) held its Annual Meeting of Shareholders on November&#160;14, 2024 (the &#8220;Annual Meeting&#8221;). At the Annual Meeting the Company&#8217;s shareholders approved the amendment and restatement of the Coherent Corp. Omnibus Incentive Plan (the &#8220;Plan&#8221;) primarily to add additional shares to be available for awards. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A summary of the Plan was included in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on October&#160;4, 2024 (the &#8220;Proxy Statement&#8221;), under the section titled &#8220;Approval of the Amendment and Restatement of the Coherent Corp. Omnibus Incentive Plan (Proposal 3)&#8221; and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The summary of the Coherent Corp. Omnibus Incentive Plan is qualified in its entirety by reference to the full text of the Plan, which is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;5.07. Submission of Matters to a Vote of Security Holders. </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As of September&#160;11, 2024, the record date for the Annual Meeting (the &#8220;Record Date&#8221;), there were 154,407,926 shares of the Company&#8217;s common stock, no par value (&#8220;Common Stock&#8221;), outstanding and entitled to vote at the Annual Meeting. In addition, 75,000 shares of the Company&#8217;s Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock, no par value, and 140,000 shares of the Company&#8217;s Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock, no par value, were issued and outstanding as of the Record Date and entitled to vote as one class with the Common Stock on an <span style="white-space:nowrap">as-converted</span> basis. A total of 183,252,523 votes outstanding, representing approximately 90.11% of the total number of votes entitled to be cast at the Annual Meeting, were present in person or by proxy at the Annual Meeting. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At the Annual Meeting, the Company&#8217;s shareholders elected </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">James R. Anderson, Michael L. Dreyer, Stephen Pagliuca, Elizabeth A. Patrick, and Howard H. Xia as Class&#160;One Directors to serve until the Company&#8217;s 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified (&#8220;Proposal 1&#8221;). Proposal 1 received the following votes: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James R. Anderson </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:90%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">155,473,545</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">371,835</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">93,072</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael L. Dreyer </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:90%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">122,237,800</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">33,591,365</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">109,287</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stephan Pagliuca </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">138,149,390</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">17,672,313</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">116,749</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Elizabeth A. Patrick </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">149,312,988</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">6,453,652</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">171,812</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Howard H. Xia </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">805,826</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">5,476,237</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">112,493</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, the Company&#8217;s shareholders approved (on a <span style="white-space:nowrap">non-binding</span> advisory basis) the Company&#8217;s executive compensation of named executive officers in the Company&#8217;s fiscal year 2024, as disclosed in the Proxy Statement (&#8220;Proposal 2&#8221;). Proposal 2 received the following votes: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">81,584,439</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">73,548,187</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">805,826</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, the Company&#8217;s shareholders approved the amendment and restatement of the Coherent Corp. Omnibus Incentive Plan, as disclosed in the Proxy Statement (&#8220;Proposal 3&#8221;). Proposal 3 received the following votes: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">147,817,008</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">7,935,945</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">185,499</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">9,191,440</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, the Company&#8217;s shareholders ratified the selection by the Audit Committee of the Company&#8217;s Board of Directors of Ernst&#160;&amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the Company&#8217;s fiscal year ending June&#160;30, 2025 (&#8220;Proposal 4&#8221;). Proposal 4 received the following votes: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:88%;border:0;margin:0 auto">


<tr>

<td style="width:24%"/>

<td style="vertical-align:bottom"/>
<td style="width:24%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:25%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:24%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Broker</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;text-align:center">161,563,096</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,558,270</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1,008,526</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">&#8212;</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01. Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:88%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d695449dex101.htm">Coherent Corp. Omnibus Incentive Plan. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded with the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Coherent Corp.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: November&#160;15, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rob Beard</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Rob Beard</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Legal and Global Affairs Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d695449dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COHERENT CORP. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OMNIBUS
INCENTIVE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(as amended and restated effective November&nbsp;14, 2024) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><I>Purpose</I></B>. The purpose of this Coherent Corp. Omnibus Incentive Plan (previously known as the
<FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated 2018 Omnibus Incentive Plan, the &#147;Plan&#148;) is to optimize the profitability and growth of the Company by providing certain eligible persons with annual and long-term incentives to
continue in the long-term service of the Company, and to create in such persons a more direct interest in the future operations of the Company by relating incentive compensation to increases in shareholder value, so that the income of those
participating in the Plan is more closely aligned with the income of the Company&#146;s shareholders. The Plan is also designed to provide Participants with an incentive for excellence in individual performance, to promote teamwork among
Participants, and to motivate, attract and retain the services of employees, consultants and directors for the Company and its subsidiaries and to provide such persons with incentives and rewards for superior performance. The Plan originally became
effective upon approval by the Company&#146;s shareholders at the 2018 annual meeting of shareholders and was amended and restated at the 2020 annual meeting of shareholders primarily to add shares to the Plan&#146;s award pool and at the 2023
annual meeting of shareholders primarily for the purposes of (i)&nbsp;adding shares to the Plan&#146;s award pool and (ii)&nbsp;extending the term of the Plan to 2033. This amendment and restatement of the Plan becomes effective upon approval of the
Company&#146;s shareholders at the 2024 annual meeting of shareholders primarily for the purposes of adding shares to the Plan&#146;s award pool. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><I>Definitions</I></B>. As used in this Plan and unless otherwise specified in the applicable Award Agreement, the following terms shall
be defined as set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.1 &#147;<I>Award</I>&#148; means any Option, Stock Appreciation Right, Restricted Shares, Restricted
Share Units, Deferred Shares, Performance Shares, or Performance Units granted under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.2 &#147;<I>Award Agreement</I>&#148;
means an agreement, certificate, resolution or other form of writing or other evidence approved by the Committee which sets forth the terms and conditions of an Award, not inconsistent with the terms of the Plan. An Award Agreement may be in an
electronic medium and may be limited to a notation on the Company&#146;s books and records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.3 &#147;<I>Base Price</I>&#148; means the
price to be used as the basis for determining the Spread upon the exercise of a Freestanding Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.4
&#147;<I>Board</I>&#148; means the Board of Directors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.5 &#147;<I>Change in Control</I>&#148; means, and shall be deemed
to occur upon: (i)&nbsp;consummation of a transaction in which the Company is merged or consolidated with another entity the result of which is that immediately following such transaction either (A)&nbsp;the persons who were the shareholders of the
Company immediately prior to the transaction have less than a majority of the combined voting power for the election of directors of the Company or the entity owning or controlling the Company immediately after the transaction; or (B)&nbsp;the
individuals who comprised the Board immediately prior to the transaction cease to be at least a majority of the members of the Board or the board of directors of the entity controlling the Company immediately after the transaction; (ii)&nbsp;any
&#147;person&#148; (as that term is used in Sections 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) becomes the &#147;beneficial owner&#148; (as defined in Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company&#146;s then outstanding securities in a transaction or
series of transactions not approved by the Board; (iii)&nbsp;consummation of a transaction in which all or substantially all of the Company&#146;s assets are sold or otherwise transferred to another corporation not controlled by, or under common
control with, the Company or to a partnership, firm, entity or one or more individuals not so controlled; (iv)&nbsp;a majority of the members of the Board consisting of persons who were not nominated for election as directors by, or on behalf of,
the Board or with the express </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
concurrence of the Board, including, for this purpose, any such person whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the
election or removal of directors or other actual or threatened solicitation of proxies or consent by or on behalf of a person other than the Board; or (v)&nbsp;any liquidation of the Company. Notwithstanding the foregoing or any provision of this
Plan to the contrary, if an Award is subject to Section&nbsp;409A (and not excepted therefrom) and a Change in Control is a distribution event for purposes of an Award, the foregoing definition of Change in Control shall be interpreted, administered
and construed in a manner necessary to ensure that the occurrence of any such event shall result in a Change in Control only if such event qualifies as a change in the ownership or effective control of a corporation, or a change in the ownership of
a substantial portion of the assets of a corporation, as applicable, within the meaning of Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.409A-3(i)(5).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.6 &#147;<I>Code</I>&#148; means the Internal Revenue Code of 1986, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.7 &#147;<I>Committee</I>&#148; means the Compensation and Human Capital Committee of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.8 &#147;<I>Common Stock</I>&#148; means the common stock, no par value, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.9 &#147;<I>Company</I>&#148; means Coherent Corp., a Pennsylvania corporation, or any successor corporation </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.10 &#147;<I>Consultant</I>&#148; means any <FONT STYLE="white-space:nowrap">non-Employee</FONT> independent contractor or other service
provider engaged by the Company or a Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.11 &#147;<I>Deferral Period</I>&#148; means the period of time during which Deferred
Shares are subject to deferral limitations under Section&nbsp;8. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.12 &#147;<I>Deferred Shares</I>&#148; means an Award pursuant to
Section&nbsp;8 of the right to receive Shares at the end of a specified Deferral Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.13 &#147;<I>Effective Date</I>&#148; means the
date this Plan is approved by the shareholders of the Company. The &#147;<I>Original Effective Date</I>&#148; means November&nbsp;9, 2018, the date the Plan was originally approved by the Company&#146;s shareholders. The &#147;2020 Restatement
Effective Date&#148; means November&nbsp;9, 2020, the date the first amendment and restatement of the Plan was approved by the Company&#146;s shareholders. The &#147;2023 Restatement Effective Date&#148; means November&nbsp;9, 2023, the date this
amendment and restatement of the Plan was approved by the Company&#146;s shareholders. The &#147;2024 Restatement Effective Date&#148; means November&nbsp;14, 2024, the date this amendment and restatement of the Plan was approved by the
Company&#146;s shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.14 &#147;<I>Employee</I>&#148; means any person, including an officer, employed by the Company or a
Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.15 &#147;<I>Fair Market Value</I>&#148; means the fair market value of the Shares as determined by the Committee from time
to time. Unless otherwise determined by the Committee, the fair market value shall be the closing sales price for the Shares reported on a consolidated basis on the New York Stock Exchange (or, if the Shares are not trading on the New York Stock
Exchange, on the principle market on which the Shares are trading) on the relevant date or, if there were no sales on such date, the closing sales price on the nearest preceding date on which sales occurred. If the Shares are not reported on the
basis of closing sale price, then the average of the highest bid and lowest ask prices shall be used to determine fair market value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.16
&#147;<I>Family Member</I>&#148; means a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mother-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">father-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">son-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">daughter-in-law,</FONT></FONT> brother, sister,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">brother-in-law,</FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sister-in-law,</FONT></FONT> including adoptive relationships, of the applicable
individual, any person sharing the applicable individual&#146;s household (other than a tenant or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employee), a trust in which any one or more of these persons have more than 50% of the beneficial interest, a foundation in which any one or more of these persons (or the applicable individual)
control the management of assets, and any other entity in which one or more of these persons (or the applicable individual) own more than 50% of the voting interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.17 &#147;<I>Freestanding Stock Appreciation Right</I>&#148; means a Stock Appreciation Right granted pursuant to Section&nbsp;6 that is not
granted in tandem with an Option or similar right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.18 &#147;<I>Grant Date</I>&#148; means the date specified by the Committee on which
a grant of an Award shall become effective, which shall not be earlier than the date on which the Committee takes action with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.19 &#147;<I>Incentive Stock Option</I>&#148; means any Option that is intended to qualify as an &#147;incentive stock option&#148; under
Code Section&nbsp;422 or any successor provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.20 &#147;<I><FONT STYLE="white-space:nowrap">Non-employee</FONT> Director</I>&#148;
means a member of the Board who is not an Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.21 &#147;<I>Nonqualified Stock Option</I>&#148; means an Option that is not
intended to qualify as an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.22 &#147;<I>Option</I>&#148; means any option to purchase Shares granted under
Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.23 &#147;<I>Optionee</I>&#148; means a Participant who holds an outstanding Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.24 &#147;<I>Option Price</I>&#148; means the purchase price payable upon the exercise of an Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.25 &#147;<I>Participant</I>&#148; means an Employee, Consultant or Non-employee Director who is selected by the Committee to receive
benefits under this Plan, provided that only Employees shall be eligible to receive grants of Incentive Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.26
&#147;<I>Performance Objectives</I>&#148; means any performance objectives established pursuant to this Plan for Participants who have received performance-based Awards, which may be any financial performance measures, strategic goals or milestones,
individual performance goals, or other objective or subjective performance goals selected by the Committee. Performance Objectives may be described in terms of Company-wide objectives or objectives that are related to the performance of the
individual Participant or the Subsidiary, division, department or function within the Company or Subsidiary in which the Participant is employed. Performance Objectives may be measured on an absolute or relative basis. The Committee may determine
that certain adjustments shall apply, in whole or in part, in such manner as determined by the Committee, to exclude the effect of any of the following events or any other events that occur during a performance period: the impairment of tangible or
intangible assets; litigation or claim judgments or settlements; the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported results; business combinations, reorganizations and/or restructuring
programs, including, but not limited to, reductions in force and early retirement incentives; currency fluctuations; and any unusual, infrequent or <FONT STYLE="white-space:nowrap">non-recurring</FONT> items, including, but not limited to, such
items described in management&#146;s discussion and analysis of financial condition and results of operations or the financial statements and notes thereto appearing in Company&#146;s annual report for the applicable period. If the Committee
determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances or individual performance renders the Performance
Objectives unsuitable, the Committee may modify such Performance Objectives or the related minimum acceptable level of achievement, in whole or in part, upward or downward, as the Committee deems appropriate and equitable; provided, however, that no
such adjustment shall be authorized to the extent that such authority would be inconsistent with the Plan or any award meeting the requirements (or an applicable exception thereto) of Section&nbsp;409A or other applicable statutory provision. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.27 &#147;<I>Performance Period</I>&#148; means the period of time within which the
Performance Objectives relating to a performance-based Award must be achieved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.28 &#147;<I>Performance Share</I>&#148; means a
bookkeeping entry that records the equivalent of one Share awarded pursuant to Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.29 &#147;<I>Performance Unit</I>&#148;
means a bookkeeping entry that records a unit equivalent to $1.00 awarded pursuant to Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.30 &#147;<I>Predecessor
Plans</I>&#148; means (i)&nbsp;as of the Original Effective Date, the <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated 2005 Omnibus Incentive Plan, the <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated 2009 Omnibus Incentive Plan,
and/or the <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated Second Amended and Restated 2012 Omnibus Incentive Plan, (ii)&nbsp;as of the 2020 Restatement Effective Date, the Finisar Corporation 2005 Stock Incentive Plan (As Amended and
Restated Effective September&nbsp;2, 2014), and (iii)&nbsp;as of the 2023 Restatement Effective Date, the Coherent, Inc. 2011 Equity Incentive Plan and the Coherent, Inc. Equity Incentive Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.31 &#147;<I>Restricted Shares</I>&#148; means an Award of Shares that are granted under and subject to the terms, conditions and
restrictions described in Section&nbsp;7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.32 &#147;<I>Restricted Share Units</I>&#148; means an Award of the right to receive (as the
Committee determines) Shares, cash or other consideration equal to the Fair Market Value of a Share for each Restricted Share Unit, granted under and subject to the terms, conditions and restrictions described in Section&nbsp;7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.33 &#147;<I>Section</I><I></I><I>&nbsp;409A</I>&#148; means Section&nbsp;409A of the Code, the regulations and other binding guidance
promulgated thereunder, as they may now exist or may be amended from time to time, or any successor to such section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.34
&#147;<I>Separation from Service</I>&#148; means a Participant&#146;s termination of service with the Company and its Subsidiaries, as determined by the Company, which determination shall be final, binding and conclusive; provided that if an Award
is subject to Section&nbsp;409A and is to be distributed on a Separation from Service, then the definition of Separation from Service for such purpose shall comply with the definition provided in Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.35 &#147;<I>Shares</I>&#148; means shares of Common Stock, as adjusted in accordance with Section&nbsp;12. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.36 &#147;<I>Specified Employee</I>&#148; means a &#147;specified employee&#148; under Section&nbsp;409A, as determined in accordance with
the procedures established by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.37 &#147;<I>Spread</I>&#148; means, in the case of a Freestanding Stock Appreciation Right,
the amount by which the Fair Market Value on the date when any such right is exercised exceeds the Base Price specified in such right or, in the case of a Tandem Stock Appreciation Right, the amount by which the Fair Market Value on the date when
any such right is exercised exceeds the Option Price specified in the related Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.38 &#147;<I>Stock Appreciation Right</I>&#148;
means a right granted under Section&nbsp;6, including a Freestanding Stock Appreciation Right or a Tandem Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.39
&#147;<I>Subsidiary</I>&#148; means a corporation or other entity in which the Company has a direct or indirect ownership or other equity interest, including any such corporation or other entities which become a Subsidiary after adoption of the
Plan; provided that for purposes of determining whether any person may be a Participant for purposes of any grant of Incentive Stock Options, &#147;Subsidiary&#148; means any subsidiary corporation within the meaning of the Code Section&nbsp;424(f)
or any successor provision thereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.40 &#147;<I>Substitute Award</I>&#148; means any Award granted in assumption of or in
substitution for an award for an employee or other service provider of a company or business acquired by the Company or a Subsidiary or with which the Company or a Subsidiary combines. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.41 &#147;<I>Tandem Stock Appreciation Right</I>&#148; means a Stock Appreciation Right granted pursuant to Section&nbsp;6 that is granted in
tandem with an Option or any similar right granted under any other plan of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.42 &#147;<I>Ten Percent Stockholder</I>&#148;
means an individual who owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Section&nbsp;424(d) of
the Code shall be applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B>Shares Available Under the Plan; Maximum Awards.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.1 <I>Reserved Shares</I>. Subject to adjustment as provided in Section&nbsp;12, the maximum number of Shares that may be delivered pursuant
to Awards shall not exceed the sum of (i) 3,355,000 Shares, plus (ii)&nbsp;Shares with respect to any of the awards granted under a Predecessor Plan, which are outstanding as of the Original Effective Date, 2020 Restatement Effective Date, or 2023
Restatement Effective Date, as applicable, that expire unexercised or are terminated, surrendered, or forfeited, in whole or in part, from and after the applicable Effective Date, plus (iii)&nbsp;effective upon approval by the Company&#146;s
shareholders at the Company&#146;s 2020 annual meeting of shareholders, 6,000,000 Shares, plus (iv)&nbsp;effective upon approval by the Company&#146;s shareholders at the Company&#146;s 2023 annual meeting of shareholders, 3,900,000 Shares, plus
(v)&nbsp;effective upon approval by the Company&#146;s shareholders at the Company&#146;s 2024 annual meeting of shareholders, 3,360,000 Shares. Such Shares may be Shares of original issuance, Shares held in treasury, or Shares that have been
reacquired by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.2 <I>ISO Limit</I>. Subject to adjustment as provided in Section&nbsp;12, the maximum number of Shares that
may be delivered pursuant to the exercise of Incentive Stock Options shall not exceed 12,350,000 Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.3 <I>Predecessor Plan
Awards</I>. Upon the applicable Effective Date, no additional options or other awards shall be made pursuant to a Predecessor Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.4
<I>Share Counting Rules</I>. The following Share counting rules shall apply under the Plan: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Forfeited Awards. To the extent that
Awards expire or are terminated, surrendered, or forfeited, in whole or in part, the Shares covered thereby shall remain available under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Cash-Settled Awards. Awards paid or settled solely in cash shall not reduce the number of Shares available for Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Substitute Awards. In the case of any Substitute Award, such Substitute Award shall not be counted against the number of Shares
reserved under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) No Net Counting of Options or Stock Appreciation Rights. The full number of Shares with respect to which
an Option or Stock Appreciation Right is granted shall count against the aggregate number of Shares available for grant under the Plan. Accordingly, if in accordance with the Plan, a Participant pays the Option Price for an Option by either
tendering previously owned Shares or having the Company withhold Shares, then such Shares surrendered to pay the Option Price shall continue to count against the aggregate number of Shares available for grant under the Plan set forth in
Section&nbsp;3.1. In addition, if in accordance with the Plan, a Participant satisfies any tax withholding requirement with respect to any taxable event arising as a result of the Plan with respect to an Option or Stock Appreciation
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Right by either tendering previously owned Shares or having the Company withhold Shares, then such Shares surrendered to satisfy such tax withholding requirements shall continue to count against
the aggregate number of Shares available for grant under the Plan set forth in Section&nbsp;3.1. Any Shares repurchased by the Company with cash proceeds from the exercise of Options shall not be added back to the pool of Shares available for grant
under the Plan set forth in Section&nbsp;3.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Withholding Taxes for Awards Other than Options and Stock Appreciation Rights. If in
accordance with the Plan, a Participant satisfies any tax withholding requirement with respect to any taxable event arising as a result of the Plan for any Award other than an Option or Stock Appreciation Right by either tendering previously owned
Shares or having the Company withhold Shares, then such tendered or withheld Shares shall not be counted against the number of Shares reserved under the Plan and shall again be available for the grant of future Awards under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.5 <I>Maximum Calendar Year Award for Non-employee Directors</I>. The maximum value of Awards granted during any fiscal year to any <FONT
STYLE="white-space:nowrap">Non-employee</FONT> Director, taken together with any cash fees paid to that <FONT STYLE="white-space:nowrap">Non-employee</FONT> Director during the fiscal year and the value of awards granted to the <FONT
STYLE="white-space:nowrap">Non-employee</FONT> Director under any other equity compensation plan of the Company during the fiscal year, shall not exceed the following in total value (based on the Fair Market Value of the Shares underlying the Award
as of the Grant Date for Awards other than Options and Stock Appreciation Rights, and based on the Grant Date fair value for accounting purposes for Options and Stock Appreciation Rights): (1) $550,000 for each
<FONT STYLE="white-space:nowrap">Non-employee</FONT> Director other than the Chair of the Board (if applicable), and (2) $850,000 for the <FONT STYLE="white-space:nowrap">non-employee</FONT> Chair of the Board (if applicable); provided, however,
that awards granted to <FONT STYLE="white-space:nowrap">Non-employee</FONT> Directors upon their initial election to the Board shall not count towards the limits in this paragraph. The Board may make exceptions to the limits in this paragraph in
extraordinary circumstances for individual Non-employee Directors; provided that the <FONT STYLE="white-space:nowrap">Non-employee</FONT> Director receiving such additional compensation may not participate in the decision to award such compensation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><I>Plan Administration</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.1 <I>Authority of Committee</I>. This Plan shall be administered by the Committee, provided that the full Board may at any time act as the
Committee. Subject to the terms of the Plan and applicable law, and in addition to other express powers and authorizations conferred on the Committee by the Plan, the Committee shall have full power and discretionary authority to decide all matters
relating to the administration and interpretation of the Plan, provided, however, that ministerial responsibilities of the Plan (e.g., management of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> matters)
may be delegated to the Company&#146;s officers, as set forth in Section&nbsp;4.2 below. The Committee&#146;s powers include, without limitation, the authority to: (i)&nbsp;designate Participants; (ii)&nbsp;determine the type or types of Awards to
be granted to a Participant; (iii)&nbsp;determine the number of Shares, or the relative value, to be covered by, or with respect to which payments, rights, or other matters are to be calculated in connection with, Awards; (iv)&nbsp;determine the
terms and conditions of any Award; (v)&nbsp;determine whether, to what extent, and under what circumstances Awards may be settled or exercised in cash, Shares, other securities, other Awards or other property, or canceled, forfeited, or suspended
and the method or methods by which Awards may be settled, exercised, canceled, forfeited, or suspended; (vi)&nbsp;determine whether, to what extent, and under what circumstances cash, Shares, other securities, other Awards, other property, and other
amounts payable with respect to an Award shall be deferred either automatically or at the election of the holder thereof or of the Board; (vii)&nbsp;interpret and administer the Plan and any instrument or agreement relating to, or Award made under,
the Plan; (viii)&nbsp;establish, amend, suspend, or waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of the Plan; (ix)&nbsp;advance the lapse of any waiting period, accelerate any
exercise date, waive or modify any restriction applicable to Awards (except those restrictions imposed by law); (x) correct any defect or supply any omission or reconcile any inconsistency in the Plan or in any Award Agreement in the manner and to
the extent it shall deem expedient to carry the Plan into effect; and (xi)&nbsp;make any other determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan. All decisions and
determinations of the Committee shall be final, conclusive and binding on the Company, the Participant and any and all interested parties. Except to the extent prohibited by applicable law or regulation, the Committee may allocate all or any portion
of its responsibilities and powers to any one or more of its members and may revoke any such allocation at any time. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.2 <I>Committee Delegation</I>. Except to the extent prohibited by applicable law or
regulation, the Committee may delegate all or any portion of its responsibilities and powers to any person or persons selected by it, and may revoke such delegation at any time. The Committee may, with respect to Participants who are not directors
or executive officers subject to filing requirements of Section&nbsp;16 of the Exchange Act, delegate to one or more officers of the Company the authority to grant Awards to Participants, provided that the Committee shall have fixed the total number
of Shares subject to such Awards. No officer to whom administrative authority has been delegated pursuant to this provision may waive or modify any restriction applicable to an award to such officer under the Plan or further delegate such
officer&#146;s authority under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.3 <I>Clawbacks</I>. Awards are subject to (i)&nbsp;any policy the Company may adopt from time
to time regarding the recovery of erroneously awarded compensation and (ii)&nbsp;any applicable law, rule, and/or regulation governing the recovery of erroneously awarded compensation &#150; including, the listing standards of the New York Stock
Exchange or any other exchange on which the securities of the Company are listed. By accepting an Award, a Participant acknowledges and agrees to be bound by and comply with any such policy, applicable law, rule, and regulation and to take any
remedial and recovery action permitted and/or required by law, as determined by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.4 <I>No Liability</I>. No member of the
Committee shall be liable to any person for any such action taken or determination made in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><I>Options</I></B>. The
Committee may from time to time authorize grants to Participants of options to purchase Shares upon such terms and conditions as the Committee may determine in accordance with the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.1 <I>Number of Shares</I>. Each grant shall specify the number of Shares to which it pertains. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.2 <I>Option Price</I>. Each grant shall specify an Option Price per Share, which shall be equal to or greater than the Fair Market Value per
Share on the Grant Date; provided, however, that in the event that a Participant is a Ten Percent Stockholder as of the Grant Date, the Option Price of an Option granted to such Participant that is intended to be an Incentive Stock Option shall be
not less than 110% of the Fair Market Value of a Share on the Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.3 <I>Consideration</I>. Each grant shall specify the form of
consideration to be paid in satisfaction of the Option Price and the manner of payment of such consideration, which may include (i)&nbsp;cash in the form of currency or check or other cash equivalent acceptable to the Company,
(ii)&nbsp;nonforfeitable, unrestricted Shares owned by the Optionee which have a value at the time of exercise that is equal to the Option Price, (iii)&nbsp;any other legal consideration that the Committee may deem appropriate, including without
limitation any form of consideration authorized under Section&nbsp;5.4, on such basis as the Committee may determine in accordance with this Plan, or (iv)&nbsp;any combination of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.4 <I>Cashless Exercise</I>. To the extent permitted by applicable law, any grant may provide for the deferred payment of the Option Price
from the proceeds of the sale through a bank or broker on the date of exercise of some or all of the Shares to which the exercise relates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.5 <I>Performance-Based Options</I>. Any grant of an Option may specify Performance Objectives that must be achieved as a condition to the
exercise of the Option. Each grant of an Option may specify in respect of the specified Performance Objectives a minimum acceptable level of achievement below which no portion of the Option will be exercisable and may set forth a formula for
determining the portion of the Option to be exercisable if performance is at or above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Objectives. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.6 <I>Vesting</I>. Each Option grant may specify a period of continuous employment of the
Optionee by the Company or any Subsidiary (or, in the case of a Non-employee Director, service on the Board) that is necessary before the Options or portions thereof shall become exercisable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.7 <I>ISO Dollar Limitation</I>. Options granted under this Plan may be Incentive Stock Options, Nonqualified Stock Options or a combination
of the foregoing, provided that only Nonqualified Stock Options may be granted to Non-employee Directors. Each grant shall specify whether (or the extent to which) the Option is an Incentive Stock Option or a Nonqualified Stock Option.
Notwithstanding any such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Options designated as Incentive Stock Options are exercisable for the first time by an Optionee during any calendar year
(under all plans of the Company) exceeds $100,000 or such other amount limitation as may be provided in the Code, such Options shall be treated as Nonqualified Stock Options. The terms of any Incentive Stock Option granted under this Plan shall
comply in all respects with the provisions of Code Section&nbsp;422, or any successor provision thereto, and any regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.8 <I>Exercise Period</I>. Each Option shall be exercisable at such times and subject to such terms and conditions as the Committee may, in
its sole discretion, specify in the applicable Award Agreement or thereafter. No Option granted under this Plan may be exercised more than ten years from the Grant Date; provided, however, that in the event that the Participant is a Ten Percent
Stockholder, an Option granted to such Participant that is intended to be an Incentive Stock Option at the Grant Date shall not be exercisable after the expiration of five years from its Grant Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.9 <I>Award Agreement</I>. Each grant shall be evidenced by an Award Agreement containing such terms and provisions as the Committee may
determine consistent with this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.10 <I>No Dividends or Dividend Equivalents</I>. Options shall not accrue or pay dividends or
dividend equivalents with respect to the Shares underlying the Option. A Participant shall not have the rights of a shareholder as to the Shares underlying an Option unless and until the Option has been duly exercised and Shares have been issued.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><I>Stock Appreciation Rights</I></B>. The Committee may also authorize grants to Participants of Stock Appreciation Rights. A Stock
Appreciation Right is the right of the Participant to receive from the Company an amount, which shall be determined by the Committee and shall be expressed as a percentage (not exceeding 100 percent) of the Spread at the time of the exercise of such
right. Any grant of Stock Appreciation Rights under this Plan shall be upon such terms and conditions as the Committee may determine in accordance with the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.1 <I>Payment in Cash or Shares</I>. Any grant may specify that the amount payable upon the exercise of a Stock Appreciation Right may be
paid by the Company in cash, Shares or any combination thereof and may (i)&nbsp;either grant to the Participant, or reserve to the Committee, the right to elect among those alternatives, or (ii)&nbsp;preclude the right of the Participant to receive,
and the Company to issue, Shares or other equity securities in lieu of cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.2 <I>Maximum SAR Payment</I>. Any grant may specify that
the amount payable upon the exercise of a Stock Appreciation Right shall not exceed a maximum amount specified by the Committee on the Grant Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.3 <I>Exercise Period</I>. Any grant may specify (i)&nbsp;a waiting period or periods before Stock Appreciation Rights shall become
exercisable and (ii)&nbsp;permissible dates or periods on or during which Stock Appreciation Rights shall be exercisable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.4
<I>Performance-Based Stock Appreciation Rights</I>. Any grant of a Stock Appreciation Right may specify Performance Objectives that must be achieved as a condition to the exercise of the Stock Appreciation Right. Each grant of a Stock Appreciation
Right may specify in respect of the specified Performance Objectives a minimum acceptable level of achievement below which no portion of the Stock Appreciation Right will be exercisable and may set forth a formula for determining the portion of the
Stock Appreciation Right to be exercisable if performance is at or above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Objectives. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.5 <I>Award Agreement</I>. Each grant shall be evidenced by an Award Agreement which shall
describe the subject Stock Appreciation Rights, identify any related Options, state that the Stock Appreciation Rights are subject to all of the terms and conditions of this Plan and contain such other terms and provisions as the Committee may
determine consistent with this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.6 <I>Tandem Stock Appreciation Rights</I>. Each grant of a Tandem Stock Appreciation Right shall
provide that such Tandem Stock Appreciation Right may be exercised only (i)&nbsp;at a time when the related Option (or any similar right granted under any other plan of the Company) is also exercisable and the Spread is positive; and (ii)&nbsp;by
surrender of all or a portion of the related Option (or such other right) for cancellation in an amount equal to the portion of the Tandem Stock Appreciation Right so exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.7 <I>Exercise Period</I>. No Stock Appreciation Right granted under this Plan may be exercised more than ten years from the Grant Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.8 <I>Freestanding Stock Appreciation Rights</I>. Regarding Freestanding Stock Appreciation Rights only: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Each grant shall specify in respect of each Freestanding Stock Appreciation Right a Base Price per Share, which shall be equal to or
greater than the Fair Market Value on the Grant Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Successive grants may be made to the same Participant regardless of whether
any Freestanding Stock Appreciation Rights previously granted to such Participant remain unexercised; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Each grant shall specify
the period or periods of continuous employment or service of the Participant by the Company or any Subsidiary that are necessary before the Freestanding Stock Appreciation Rights or installments thereof shall become exercisable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.9 <I>No Dividends or Dividend Equivalents</I>. Stock Appreciation Rights shall not accrue or pay dividends or dividend equivalents with
respect to the Shares underlying the Award. A Participant shall not have the rights of a shareholder as to the Shares underlying a Stock Appreciation Right unless and until the Stock Appreciation Right has been duly exercised and Shares have been
issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><I>Restricted Shares and Restricted Share Units</I></B>. The Committee may also authorize grants to Participants of
Restricted Shares and Restricted Share Units upon such terms and conditions as the Committee may determine in accordance with the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.1 <I>Number of Shares</I>. Each grant shall specify the number of Shares to be issued to a Participant pursuant to the Award of Restricted
Shares or Restricted Shares Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.2 <I>Consideration</I>. Each grant may be made without additional consideration from the Participant
or in consideration of a payment by the Participant that is less than the Fair Market Value on the Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.3 <I>Forfeiture/Transfer
Restrictions</I>. Each grant of Restricted Shares and Restricted Share Units shall specify the duration of the period during which, and the conditions under which, the Restricted Shares or Restricted Share Units may be forfeited to the Company, and
the other terms and conditions of such Awards. Restricted Shares and Restricted Share Units may not be sold, assigned, transferred, pledged or otherwise encumbered, except, in the case of Restricted Shares, as provided in the Plan or the applicable
Award Agreements. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.4 <I>Rights/Dividends and Dividend Equivalents</I>. Each grant of Restricted Shares shall
constitute an immediate transfer of the ownership of Shares to the Participant in consideration of the performance of services, subject to terms and conditions described in this Section&nbsp;7 and in the Award Agreement evidencing such Award and
shall entitle the Participant to dividend, voting and other ownership rights. Each grant of Restricted Share Units shall constitute a right to receive Shares, cash or other consideration equal to the Fair Market Value of a Share for each Restricted
Share Unit granted, subject to the terms and conditions described in this Section&nbsp;7 and in the Award Agreement evidencing such Award. The Committee may grant dividend equivalent rights to Participants in connection with Awards of Restricted
Share Units. The Committee may specify whether such dividend or dividend equivalents shall be paid or distributed when accrued, deferred (with or without interest), or reinvested, or deemed to have been reinvested, in additional Shares; provided,
however, that notwithstanding any provision in the Plan to the contrary, in no event shall dividends or dividend equivalents vest or otherwise be paid out prior to the time that the underlying Award (or portion thereof) has vested and, accordingly,
will be subject to cancellation and forfeiture if such Award does not vest (including for both time-based and performance-based Awards). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.5 <I>Stock Certificate</I>. At the discretion of the Committee, the Company need not issue stock certificates representing Restricted Shares
and such Restricted Shares may be evidenced in book entry form on the books and records of the Company&#146;s transfer agent. If certificates are issued for Restricted Shares, unless otherwise directed by the Committee, all certificates representing
Restricted Shares, together with a stock power that shall be endorsed in blank by the Participant with respect to such Shares, shall be held in custody by the Company until all restrictions thereon have lapsed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.6 <I>Performance-Based Restricted Shares or Restricted Share Units</I>. Any grant or the vesting thereof may be further conditioned upon the
attainment of Performance Objectives established by the Committee in accordance with the applicable provisions of Section&nbsp;9 regarding Performance Shares and Performance Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.7 <I>Award Agreements</I>. Each Award of Restricted Shares or Restricted Share Units shall be evidenced by an Award Agreement containing
such terms, and provisions as the Committee may determine consistent with this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><I>Deferred Shares</I></B>. To the extent
consistent with the provisions of Section&nbsp;18 of this Plan, the Committee may authorize grants of Deferred Shares to Participants upon such terms and conditions as the Committee may determine in accordance with the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.1 <I>Deferred Compensation</I>. Each grant shall constitute the agreement by the Company to issue or transfer Shares to the Participant in
the future in consideration of the performance of services, subject to the fulfillment during the Deferral Period of such conditions as the Committee may specify. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.2 <I>Consideration</I>. Each grant may be made without the payment of additional consideration from the Participant or in consideration of a
payment by the Participant that is less than the Fair Market Value on the Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.3 <I>Deferral Period</I>. Each grant shall
provide that the Deferred Shares covered thereby shall be subject to a Deferral Period, which shall be fixed by the Committee on the Grant Date, and any grant or sale may provide for the earlier termination of such period in the event of a Change in
Control of the Company or other similar transaction or event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.4 <I>Dividend Equivalents and Other Ownership Rights</I>. During the
Deferral Period, the Participant shall not have any right to transfer any rights under the Award, shall not have any rights of ownership in the Deferred Shares and shall not have any right to vote such Deferred Shares, but the Committee may on or
after the Grant Date authorize the payment of dividend equivalents on such Deferred Shares in cash (with or without interest) or additional Shares on a current, deferred or contingent basis; provided, however, that notwithstanding any provision in
the Plan to the contrary, in no event shall such dividend equivalents vest or otherwise be paid out prior to the time that the underlying Award (or portion thereof) has vested and, accordingly, will be subject to cancellation and forfeiture if such
Award does not vest (including for both time-based and performance-based Awards). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.5 <I>Performance Objectives</I>. Any grant or the vesting thereof may be further
conditioned upon the attainment of Performance Objectives established by the Committee in accordance with the applicable provisions of Section&nbsp;9 regarding Performance Shares and Performance Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.6 <I>Award Agreement</I>. Each grant shall be evidenced by an Award Agreement containing such terms and provisions as the Committee may
determine consistent with this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><I>Performance Shares and Performance Units</I></B>. The Committee may also authorize grants
of Performance Shares and Performance Units, which shall become payable to the Participant only upon the achievement of specified Performance Objectives, upon such terms and conditions as the Committee may determine in accordance with the following
provisions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.1 <I>Number of Performance Shares or Units</I>. Each grant shall specify the number of Performance Shares or Performance
Units to which it pertains, which may be subject to adjustment to reflect changes in compensation or other factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.2 <I>Performance
Period</I>. The Performance Period with respect to each Performance Share or Performance Unit shall be as set forth in the Award Agreement and may be subject to earlier termination in the event of a Change in Control of the Company or other similar
transaction or event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.3 <I>Performance Objectives</I>. Each grant shall specify the Performance Objectives that must be achieved by the
Participant or the Company, as applicable, in order for the Award to be earned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.4 <I>Threshold Performance Objectives</I>. Each grant
may specify in respect of the specified Performance Objectives a minimum acceptable level of achievement below which no payment will be made and may set forth a formula for determining the amount of any payment to be made if performance is at or
above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.5 <I>Payment of
Performance Shares and Units</I>. Each grant shall specify the time and manner of payment of Performance Shares or Performance Units that shall have been earned, and any grant may specify that any such amount may be paid by the Company in cash,
Shares or any combination thereof and may either grant to the Participant or reserve to the Committee the right to elect among those alternatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.6 <I>Maximum Payment</I>. Any grant of Performance Shares or Performance Units may specify that the amount payable, or the number of Shares
issued, with respect thereto may not exceed a maximum specified by the Committee on the Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.7 <I>Dividend Equivalents</I>. The
Committee may grant dividend equivalent rights to Participants in connection with Awards of Performance Shares. The Committee may specify whether such dividend equivalents shall be paid or distributed when accrued, deferred (with or without
interest), or deemed to have been reinvested in additional Shares; provided, however, that notwithstanding any provision in the Plan to the contrary, in no event shall such dividend equivalents vest or otherwise be paid out prior to the time that
the underlying Award (or portion thereof) has vested and, accordingly, will be subject to cancellation and forfeiture if such Award does not vest (including for both time-based and performance-based Awards). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.8 <I>Award Agreement</I>. Each grant shall be evidenced by an Award Agreement which shall state that the Performance Shares or Performance
Units are subject to all of the terms and conditions of this Plan and such other terms and provisions as the Committee may determine consistent with this Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B><I>Change in Control</I></B>. Upon a Change in Control and except as may otherwise be
provided in the applicable Award Agreement, either of the following provisions shall apply, depending on whether, and the extent to which, Awards are assumed, converted or replaced by the resulting entity in the Change in Control: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.1 <I>Awards Assumed, Converted or Replaced</I>. To the extent any Awards are assumed, converted or replaced by the resulting entity in the
Change in Control, if, within two years after the date of the Change in Control, a Participant has a Separation from Service either (1)&nbsp;by the Company other than for &#147;cause&#148; or (2)&nbsp;by the Participant for &#147;good reason&#148;
(each as defined in the applicable Award Agreement), then such outstanding Awards that may be exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards, other than for Performance Shares and Performance
Units, shall lapse and become vested and nonforfeitable, and for any outstanding Performance Shares and Performance Units, the target payout opportunities attainable under such Awards shall be deemed to have been fully earned as of the Separation
from Service based upon the greater of: (A)&nbsp;an assumed achievement of all relevant performance goals at the &#147;target&#148; level, or (B)&nbsp;the actual level of achievement of all relevant performance goals against target as of the
Company&#146;s fiscal quarter end preceding the Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.2 <I>Awards Not Assumed, Converted or Replaced</I>. To the extent
such Awards are not assumed, converted or replaced by the resulting entity in the Change in Control, then upon the Change in Control such outstanding Awards that may be exercised shall become fully exercisable, all restrictions with respect to such
outstanding Awards, other than for Performance and or Performance Units, shall lapse and become vested and <FONT STYLE="white-space:nowrap">non-forfeitable,</FONT> and for any outstanding Performance Shares and Performance Units, the target payout
opportunities attainable under such Awards shall be deemed to have been fully earned as of the Change in Control based upon the greater of: (A)&nbsp;an assumed achievement of all relevant performance goals at the &#147;target&#148; level, or
(B)&nbsp;the actual level of achievement of all relevant performance goals against target as of the Company&#146;s fiscal quarter end preceding the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B><I>Transferability</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.1 <I>Transfer Restrictions</I>. Except as provided in Section&nbsp;11.2, no Award granted under this Plan shall be transferable by a
Participant other than by will or the laws of descent and distribution, and Options and Stock Appreciation Rights shall be exercisable during a Participant&#146;s lifetime only by the Participant or, in the event of the Participant&#146;s legal
incapacity, by his guardian or legal representative acting in a fiduciary capacity on behalf of the Participant under state law. Any attempt to transfer an Award in violation of this Plan shall render such Award null and void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.2 <I>Limited Transfer Rights</I>. The Committee may expressly provide in an Award Agreement (or an amendment to an Award Agreement) that a
Participant may transfer such Award (other than an Incentive Stock Option), in whole or in part, to a Family Member. Subsequent transfers of Awards shall be prohibited except in accordance with this Section&nbsp;11.2. All terms and conditions of the
Award, including provisions relating to the termination of the Participant&#146;s employment or service with the Company or a Subsidiary, shall continue to apply following a transfer made in accordance with this Section&nbsp;11.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.3 <I>Restrictions on Transfer</I>. Any Award made under this Plan may provide that all or any part of the Shares that are to be issued or
transferred by the Company upon the exercise of Options or Stock Appreciation Rights, upon the termination of the Deferral Period applicable to Deferred Shares or upon payment under any grant of Performance Shares or Performance Units, or are no
longer subject to the substantial risk of forfeiture and restrictions on transfer referred to in Section&nbsp;7, shall be subject to further restrictions upon transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B><I>Adjustments</I></B>. In the event (a)&nbsp;a stock dividend, stock split, combination or exchange of Shares, recapitalization or
other change in the capital structure of the Company, (b)&nbsp;any merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">spin-out,</FONT> <FONT STYLE="white-space:nowrap">split-off,</FONT> <FONT
STYLE="white-space:nowrap">split-up,</FONT> reorganization, partial or complete liquidation or other distribution of assets (other than a normal cash dividend), issuance of rights or warrants to purchase securities or (c)&nbsp;any other corporate
transaction or event having an effect similar to any of the foregoing </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affects the Common Stock such that an adjustment is necessary in order to prevent dilution or enlargement of the benefits or potential benefits to Participants intended to be made available under
the Plan, then the Committee shall, in an equitable manner, make or provide for such adjustments in the (w)&nbsp;number of Shares covered by outstanding Awards granted hereunder, (x)&nbsp;prices per share applicable to Options and Stock Appreciation
Rights granted hereunder, (y)&nbsp;kind of shares covered thereby (including shares of another issuer) and/or (z)&nbsp;any Performance Objectives applicable to the Awards, as the Committee in its sole discretion shall determine in good faith to be
equitably required in order to prevent such dilution or enlargement of the benefits or intended benefits to Participants. Moreover, in the event of any such transaction or event, the Committee may provide in substitution for any or all outstanding
Awards under this Plan such alternative consideration as it may in good faith determine to be equitable under the circumstances and may cancel all Awards in exchange for such alternative consideration. If, in connection with any such transaction or
event in which the Company does not survive, the amount payable pursuant to any Award, based on consideration per Share to be paid in connection with such transaction or event and the Base Price, Option Price, Spread or otherwise of the Award, is
not a positive amount, the Committee may provide for cancellation of such Award without any payment to the holder thereof. The Committee may also make or provide for such adjustments in each of the limitations specified in Section&nbsp;3 as the
Committee in its sole discretion may in good faith determine to be appropriate in order to reflect any transaction or event described in this Section&nbsp;12. The Committee will not, in any case, make any of the following adjustments: (A)&nbsp;with
respect to Awards of Incentive Stock Options, no such adjustment shall be authorized to the extent that such authority would cause the Plan to violate Section&nbsp;422(b)(1) of the Code, as from time to time amended, and (B)&nbsp;with respect to any
Award subject to Section&nbsp;409A, no such adjustment shall be authorized to the extent that such authority would cause the Plan to fail to comply with Section&nbsp;409A (or an exception thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B><I>Fractional Shares</I></B>. The Company shall not be required to issue any fractional Shares pursuant to this Plan. The Committee may
provide for the elimination of fractions or for the settlement thereof in cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B><I>Withholding Taxes</I></B>. A Participant may be
required to pay to the Company, a Subsidiary or any affiliate, and the Company, Subsidiary or any affiliate shall have the right and is hereby authorized to withhold from any Award, from any payment due or transfer made under any Award or under the
Plan or from any compensation or other amount owing to a Participant an amount (in cash, Shares, other securities, other Awards or other property) sufficient to cover any federal, state, local or foreign income taxes or such other applicable taxes
required by law in respect of an Award, its exercise, or any payment or transfer under an Award or under the Plan and to take such other action as may be necessary in the opinion of the Company to satisfy all obligations for the payment of such
taxes. The Company may, in its discretion, permit a Participant (or any beneficiary or other Person entitled to act) to elect to pay a portion or all of the amount such taxes in such manner as the Committee shall deem to be appropriate, including,
but not limited to, authorizing the Company to withhold, or agreeing to surrender to the Company, Shares owned by such Participant or a portion of such forms of payment that would otherwise be distributed pursuant to an Award in an amount not to
exceed the amount of applicable taxes based on not more than the maximum statutory rates (or on such other basis that would not trigger adverse accounting treatment under applicable accounting policies). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B><I>Certain Terminations of Employment, Hardship and Approved Leaves of Absence</I></B>. Notwithstanding any other provision of this
Plan to the contrary, in the event of termination of employment or service by reason of death, disability, normal retirement, early retirement with the consent of the Company or leave of absence approved by the Company, or in the event of hardship
or other special circumstances, of a Participant who holds an Option or Stock Appreciation Right that is not immediately and fully exercisable, any Restricted Shares or Restricted Share Units as to which the substantial risk of forfeiture or the
prohibition or restriction on transfer has not lapsed, any Deferred Shares as to which the Deferral Period is not complete, any Performance Shares or Performance Units that have not been fully earned, or any Shares that are subject to any transfer
restriction pursuant to Section&nbsp;11.3, the Committee may in its sole discretion take any action that it deems to be equitable under the circumstances or in the best interests of the Company, including, without limitation, waiving or modifying
any limitation or requirement with respect to any Award under this Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <B><I>Foreign Participants</I></B>. In order to facilitate the making of any grant or
combination of grants under this Plan, the Committee may provide for such special terms for Awards to Participants who are foreign nationals, or who are employed by or perform services for the Company or any Subsidiary outside of the United States
of America, as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements to, or amendments, restatements or alternative versions of, this
Plan as it may consider necessary or appropriate for such purposes without thereby affecting the terms of this Plan as in effect for any other purpose, provided that no such supplements, amendments, restatements or alternative versions shall include
any provisions that are inconsistent with the terms of this Plan, as then in effect, unless this Plan could have been amended to eliminate such inconsistency without further approval by the shareholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <B><I>Amendments and Other Matters</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.1 <I>Plan Amendments</I>. This Plan may be amended from time to time by the Board, but no such amendment shall increase any of the
limitations specified in Section&nbsp;3, other than to reflect an adjustment made in accordance with Section&nbsp;12, without the further approval of the shareholders of the Company. The Board may condition any amendment on the approval of the
shareholders of the Company if such approval is necessary or deemed advisable with respect to the applicable listing or other requirements of a national securities exchange or other applicable laws, policies or regulations. Notwithstanding anything
to the contrary contained herein, the Committee may also make any amendments or modifications to this Plan and/or outstanding Awards in order to conform the provisions of the Plan or such Awards with Code Section&nbsp;409A regardless of whether such
modification, amendment, or termination of the Plan shall adversely affect the rights of a Participant under the Plan or an Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.2 <I>Award Deferrals</I>. The Committee may permit Participants to elect to defer the issuance of Shares or the settlement or payment of
Awards in cash under the Plan pursuant to such rules, procedures or programs as it may establish for purposes of this Plan. In the case of an award of Restricted Shares, the deferral may be effected by the Participant&#146;s agreement to forego or
exchange his or her award of Restricted Shares and receive an award of Deferred Shares. The Committee also may provide that deferred settlements include the payment or crediting of interest on the deferral amounts, or the payment or crediting of
dividend equivalents where the deferral amounts are denominated in Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.3 <I>Conditional Awards</I>. The Committee may condition
the grant of any Award or combination of Awards under the Plan on the surrender or deferral by the Participant of his or her right to receive a cash award or other compensation otherwise payable by the Company or any Subsidiary to the Participant.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.4 <I>Repricing Prohibited</I>. Except in connection with a corporate transaction involving the Company as provided for in
Section&nbsp;12, the terms of an outstanding Option or Stock Appreciation Right may not be amended by the Committee to reduce the exercise price of outstanding Options or Stock Appreciation Rights, or cancel outstanding Options or Stock Appreciation
Rights in exchange for cash, other Awards, Options or Stock Appreciation Rights with an exercise price that is less than the exercise price of the original Options or Stock Appreciation Rights without the approval of the shareholders of the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.5 <I>No Employment Right</I>. This Plan shall not confer upon any Participant any right with respect to continuance of employment or
other service with the Company or any Subsidiary and shall not interfere in any way with any right that the Company or any Subsidiary would otherwise have to terminate any Participant&#146;s employment or other service at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <B><I>Section 409A</I></B>. Notwithstanding any provision of the Plan or an Award Agreement to the contrary, if any Award or benefit
provided under this Plan is subject to the provisions of Section&nbsp;409A, the provisions of the Plan and any applicable Award Agreement shall be administered, interpreted and construed in a manner necessary to comply with Section&nbsp;409A or an
exception thereto (or disregarded to the extent such provision cannot be so administered, interpreted or construed). The following provisions shall apply, as applicable: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.1 If a Participant is a Specified Employee and a payment subject to Section&nbsp;409A
(and not excepted therefrom) to the Participant is due upon Separation from Service, such payment shall be delayed for a period of six (6)&nbsp;months after the date the Participant Separates from Service (or, if earlier, the death of the
Participant). Any payment that would otherwise have been due or owing during such <FONT STYLE="white-space:nowrap">six-month</FONT> period will be paid immediately following the end of the <FONT STYLE="white-space:nowrap">six-month</FONT> period in
the month following the month containing the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the date of termination unless another compliant date is specified in the applicable agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.2 For purposes of Section&nbsp;409A, and to the extent applicable to any Award or benefit under the Plan, it is intended that distribution
events qualify as permissible distribution events for purposes of Section&nbsp;409A and shall be interpreted and construed accordingly. With respect to payments subject to Section&nbsp;409A, the Company reserves the right to accelerate and/or defer
any payment to the extent permitted and consistent with Section&nbsp;409A. Whether a Participant has Separated from Service or employment will be determined based on all of the facts and circumstances and, to the extent applicable to any Award or
benefit, in accordance with the guidance issued under Section&nbsp;409A. For this purpose, a Participant will be presumed to have experienced a Separation from Service when the level of bona fide services performed permanently decreases to a level
less than twenty percent (20%) of the average level of bona fide services performed during the immediately preceding <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36)&nbsp;month period or such other applicable period as provided by
Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.3 The Committee, in its discretion, may specify the conditions under which the payment of all or any portion of any
Award may be deferred until a later date. Deferrals shall be for such periods or until the occurrence of such events, and upon such terms and conditions, as the Committee shall determine in its discretion, in accordance with the provisions of
Section&nbsp;409A, the regulations and other binding guidance promulgated thereunder; provided, however, that no deferral shall be permitted with respect to Options, Stock Appreciation Rights and other stock rights subject to Section&nbsp;409A. An
election shall be made by filing an election with the Company (on a form provided by the Company) on or prior to December 31st of the calendar year immediately preceding the beginning of the calendar year (or other applicable service period) to
which such election relates (or at such other date as may be specified by the Committee to the extent consistent with Section&nbsp;409A) and shall be irrevocable for such applicable calendar year (or other applicable service period). To the extent
authorized, a Participant who first becomes eligible to participate in the Plan may file an election (&#147;Initial Election&#148;) at any time prior to the <FONT STYLE="white-space:nowrap">30-day</FONT> period following the date on which the
Participant initially becomes eligible to participate in the Plan (or at such other date as may be specified by the Committee to the extent consistent with Section&nbsp;409A). Any such Initial Election shall only apply to compensation earned and
payable for services rendered after the effective date of the Election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.4 The grant of
<FONT STYLE="white-space:nowrap">non-qualified</FONT> Options, Stock Appreciation Rights and other stock rights subject to Section&nbsp;409A shall be granted under terms and conditions consistent with Treas. Reg. &#167; <FONT
STYLE="white-space:nowrap">1.409A-1(b)(5)</FONT> such that any such Award does not constitute a deferral of compensation under Section&nbsp;409A. Accordingly, any such Award may be granted to Employees and Directors of the Company and its
subsidiaries and affiliates in which the Company has a controlling interest. In determining whether the Company has a controlling interest, the rules of Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.414(c)-2(b)(2)(i)</FONT> shall apply;
provided that the language &#147;at least 50 percent&#148; shall be used instead of &#147;at least 80 percent&#148; in each place it appears; provided, further, where legitimate business reasons exist (within the meaning of Treas. Reg. &#167; <FONT
STYLE="white-space:nowrap">1.409A-1(b)(5)(iii)(E)(i)),</FONT> the language &#147;at least 20 percent&#148; shall be used instead of &#147;at least 80 percent&#148; in each place it appears. The rules of Treas. Reg. &#167;&#167; <FONT
STYLE="white-space:nowrap">1.414(c)-3</FONT> and <FONT STYLE="white-space:nowrap">1.414(c)-4</FONT> shall apply for purposes of determining ownership interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.5 In no event shall any member of the Board, the Committee or the Company (or its employees, officers or directors) have any liability to
any Participant (or any other Person) due to the failure of an Award to satisfy the requirements of Section&nbsp;409A. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <B><I>Effective Date</I></B>. This amendment and restatement of the Plan shall become
effective upon its approval by the shareholders of the Company on the 2024 Restatement Effective Date. If the amendment and restatement of the Plan is not approved by the Company&#146;s shareholders, the Plan as in effect upon the 2023 Restatement
Effective Date shall remain in effect in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <B><I>Requirements of Law</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20.1 <I>General</I>. The Company shall not be required to sell or issue any Shares under any Award if the sale or issuance of such Shares
would constitute a violation by the Participant, any other individual, or the Company of any law or regulation of any governmental authority, including any federal or state securities laws or regulations. If at any time the Company determines that
the listing, registration, or qualification of any Shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a term or condition of, or in connection with, the issuance or purchase
of Shares hereunder, no Shares may be issued or sold to the Participant or any other individual exercising an Option unless such listing, registration, qualification, consent or approval shall have been effected or obtained free of any terms and
conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act of 1933 (the &#147;Securities Act&#148;), upon the exercise of
any Option or the delivery of any Shares underlying an Award, unless a registration statement under such Act is in effect with respect to the Shares covered by such Award, the Company shall not be required to sell or issue such Shares unless the
Committee has received evidence satisfactory to it that the Participant or any other individual exercising an Option may acquire such Shares under an exemption from registration under the Securities Act. The Company may, but shall not be obligated
to, register any securities covered hereby under the Securities Act. The Company shall not be obligated to take any affirmative action in order to cause the exercise of an Option or the issuance of Shares under the Plan to comply with any law or
regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option shall not be exercisable until the Shares covered by such Option are registered or are exempt from registration, the exercise of
such Option (under circumstances in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability of such an exemption. The Committee may require the Participant to sign such
additional documentation, make such representations, and furnish such information as the Committee may consider appropriate in connection with the grant of Awards or issuance or delivery of Shares in compliance with applicable laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20.2 <I>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></I>. During any time when the Company has a class of equity security registered
under Section&nbsp;12 of the Exchange Act, it is the intent of the Company that Awards and the exercise of Options granted to officers and directors hereunder will qualify for the exemption provided by Rule
<FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. To the extent that any term or condition of the Plan or action by the Committee does not comply with the requirements of Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> it
shall be deemed inoperative to the extent permitted by law and deemed advisable by the Committee, and shall not affect the validity of the Plan. In the event that Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> is revised or replaced, the
Committee may modify the Plan in any respect necessary to satisfy the requirements of, or to take advantage of any features of, the revised exemption or its replacement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <B><I>Termination</I></B>. No Award shall be granted from and after the tenth anniversary of the 2024 Restatement Effective Date or after
such earlier date that the Board shall have adopted a resolution terminating the Plan. This Plan shall remain in effect with respect to Awards outstanding at that time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <B><I>Governing Law</I></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">22.1 The validity, construction and effect of this Plan and any Award hereunder will be determined in accordance with the internal laws of the
Commonwealth of Pennsylvania without giving effect to conflict of laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">22.2 Any person who believes he or she is being denied any
benefit or right under the Plan may file a written claim with the Committee. Any claim must be delivered to the Committee within forty-five (45)&nbsp;days of the specific event giving rise to the claim. Untimely claims will not be processed and
shall be deemed denied. The Committee, or its designated agent, will notify the Participant of its decision in writing as soon as administratively practicable. Claims not responded to by the Committee in writing within
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ninety (90)&nbsp;days of the date the written claim is delivered to the Committee shall be deemed denied. The Committee&#146;s decision is final and conclusive and binding on all persons. No
lawsuit relating to the Plan may be filed before a written claim is filed with the Committee and is denied or deemed denied and any lawsuit must be filed within one year of such denial or deemed denial or be forever barred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">22.3 For purposes of resolving any lawsuit that arises under the Plan, each Participant, by virtue of receiving an Award, shall be deemed to
have submitted to and consented to the exclusive jurisdiction of the state and federal courts located in the Commonwealth of Pennsylvania and to have agreed that any related litigation shall be conducted solely in the courts of Butler County,
Pennsylvania or the federal courts for the U.S. for the Western District of Pennsylvania, where the Plan is made and to be performed, and no other courts. The Plan is not intended to be subject to the Employee Retirement Income Security Act of 1974.
</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cohr-20241114.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 11/16/2024 4:26:00 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:cohr="http://www.coherent.com/20241114"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.coherent.com/20241114"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cohr-20241114_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cohr-20241114_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cohr-20241114_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 11/16/2024 4:26:00 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cohr-20241114_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 11/16/2024 4:26:00 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cohr-20241114.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45322338416800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 14, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000820318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 14,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Coherent Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">25-1214948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">375 Saxonburg Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Saxonburg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">16056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">352-4455<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COHR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M!F_236P@R*2*Y U+2X<L-03&IAJ O<NF>3[+O,&@EXN1:T/9=1,92L88!.R
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M4$L! A0#%     @ KI-O60=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "NDV]9Y%_FNN\    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "NDV]9F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( *Z3;UFIMV#4.00  'X0   8
M      " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "NDV]9GZ ;\+$"  #B#   #0              @ %]#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( *Z3;UF7BKL<P    !,"   +              "
M 5D/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *Z3;UD<.&7J/P$  #P"   /
M              "  4(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "N
MDV]9)!Z;HJT   #X 0  &@              @ &N$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "NDV]999!YDAD!  #/ P  $P
M            @ &3$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  #=$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d695449d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cohr-20241114.xsd</File>
    <File>cohr-20241114_lab.xml</File>
    <File>cohr-20241114_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d695449d8k.htm">d695449d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d695449d8k.htm": {
   "nsprefix": "cohr",
   "nsuri": "http://www.coherent.com/20241114",
   "dts": {
    "schema": {
     "local": [
      "cohr-20241114.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cohr-20241114_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cohr-20241114_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d695449d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-11-14_to_2024-11-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d695449d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-11-14_to_2024-11-14",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d695449d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.coherent.com//20241114/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-24-260003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-260003-xbrl.zip
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MSDEKO76X4QCI,H1.+S83H2>'IB)H.5#!$(H/'#J= D7,2YN11N'\QG]DPQZ
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M;V]??_KIS]\</WSX)Q>HQ0#QFP__=L'][TFBX*359(K;_4S1AB[7>!A3N<9
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M_CWB[-^9*V<4,*=CWY?&IFRBNL2J:4_14[/>E0D*;GA9Q<.&)AIBJ:E7;PS
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MR!<A:XC$" $O@FO]31L4WR_F*L"C^]EU3;^D, T9DMG*YW1@C.QZ4$$[4;;
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MZW0\"EXK3EDT</75?COZ>.1^^!MV7:R7R>N"B^CC*:2FWEQS;]QO8:GM%QR
MF3V29>4JI/&U?(9MVB[JWA#5Q;F"H0^>#? M$Z]^5&_9!8F?/CK:I,G!8'O_
M^N_PRY\^_?+S]_\/4$L! A0#%     @ KI-O66I4'><^ P  30L  !$
M         ( !     &-O:'(M,C R-#$Q,30N>'-D4$L! A0#%     @ KI-O
M65QS5JQ<!@  OT,  !4              ( !;0,  &-O:'(M,C R-#$Q,31?
M;&%B+GAM;%!+ 0(4 Q0    ( *Z3;UE1E(L-LP0  'TJ   5
M  "  ?P)  !C;VAR+3(P,C0Q,3$T7W!R92YX;6Q02P$"% ,4    " "NDV]9
MN0O*9^H3   PN   #@              @ 'B#@  9#8Y-30T.60X:RYH=&U0
M2P$"% ,4    " "NDV]9?)@5EPM-  !)< $ $0              @ 'X(@
G9#8Y-30T.61E>#$P,2YH=&U02P4&      4 !0!  0  ,G

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>d695449d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cohr-20241114.xsd" xlink:type="simple"/>
    <context id="duration_2024-11-14_to_2024-11-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000820318</identifier>
        </entity>
        <period>
            <startDate>2024-11-14</startDate>
            <endDate>2024-11-14</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-506">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-11-14_to_2024-11-14"
      id="Hidden_dei_EntityCentralIndexKey">0000820318</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-517">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-518">2024-11-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-519">Coherent Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-520">PA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-521">001-39375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-522">25-1214948</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-523">375 Saxonburg Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-524">Saxonburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-525">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-526">16056</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-527">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-528">352-4455</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-529">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-530">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-531">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-532">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-533">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-534">COHR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-535">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-11-14_to_2024-11-14" id="ixv-536">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
